Hypertension Pulmonary Secondary
2 clinical trials · Condition
◉ Watch Hypertension Pulmonary Secondary
| Record | Firm | Date |
|---|---|---|
| Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF (NCT03541603) | Tenax Therapeutics, Inc. | 2018-11-14 |
Track Hypertension Pulmonary Secondary automatically
Every clearance here is in the API, with alerts when new ones post.